These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16190553)

  • 21. Elevated serum levels of interferon- gamma -inducible protein-10 in patients coinfected with hepatitis C virus and HIV.
    Roe B; Coughlan S; Hassan J; Grogan A; Farrell G; Norris S; Bergin C; Hall WW
    J Infect Dis; 2007 Oct; 196(7):1053-7. PubMed ID: 17763328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An artificial neural network improves the non-invasive diagnosis of significant fibrosis in HIV/HCV coinfected patients.
    Resino S; Seoane JA; Bellón JM; Dorado J; Martin-Sanchez F; Alvarez E; Cosín J; López JC; Lopéz G; Miralles P; Berenguer J
    J Infect; 2011 Jan; 62(1):77-86. PubMed ID: 21073895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic steatosis in HIV-HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype.
    Castéra L; Loko MA; Le Bail B; Coffie P; De Ledinghen V; Trimoulet P; Winnock M; Dabis F; Neau D;
    Aliment Pharmacol Ther; 2007 Dec; 26(11-12):1489-98. PubMed ID: 17903235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of liver fibrosis and cirrhosis by transient elastography among patients with chronic HBV and HCV infection in Georgia.
    Tsertsvadze T; Dolmazashvili E; Abutidze A; Sharvadze L; Karchava M
    Georgian Med News; 2008 Dec; (165):38-42. PubMed ID: 19124915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin resistance is not associated with liver fibrosis progression in HIV/hepatitis C virus-coinfected patients.
    Merchante N; Macías J; Ramayo E; Vergara S; García-García JA; Mira JA; Corzo JE; Gómez-Mateos JM; Lozano F; Pineda JA
    J Viral Hepat; 2006 Jul; 13(7):449-56. PubMed ID: 16792538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contributions to hepatic fibrosis in HIV-HCV coinfected and HCV monoinfected patients.
    Monto A; Kakar S; Dove LM; Bostrom A; Miller EL; Wright TL
    Am J Gastroenterol; 2006 Jul; 101(7):1509-15. PubMed ID: 16863554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of 99mTc-MIBI brain SPECT and proton magnetic resonance spectroscopy (1H-MRS) to assess glioma recurrence after radiotherapy.
    Palumbo B; Lupattelli M; Pelliccioli GP; Chiarini P; Moschini TO; Palumbo I; Siepi D; Buoncristiani P; Nardi M; Giovenali P; Palumbo R
    Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):88-93. PubMed ID: 16557208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3.
    Borghi V; Puoti M; Mussini C; Bellelli S; Angeletti C; Sabbatini F; Prati F; Cossarizza A; Esposito R
    Antivir Ther; 2008; 13(8):1057-65. PubMed ID: 19195331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cryoglobulinaemia vasculitis in patients coinfected with HIV and hepatitis C virus.
    Saadoun D; Aaron L; Resche-Rigon M; Pialoux G; Piette JC; Cacoub P;
    AIDS; 2006 Apr; 20(6):871-7. PubMed ID: 16549971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of transient elastometry to differentiate mild from moderate to severe liver fibrosis in HIV/HCV co-infected patients.
    Macías J; Recio E; Vispo E; Rivero A; López-Cortés LF; Ríos MJ; Merino D; González M; Barreiro P; de Lédinghen V; Quereda C; Pineda JA
    J Hepatol; 2008 Dec; 49(6):916-22. PubMed ID: 18929426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MR spectroscopy in monitoring the treatment of Wilson's disease patients.
    Tarnacka B; Szeszkowski W; Golebiowski M; Czlonkowska A
    Mov Disord; 2008 Aug; 23(11):1560-6. PubMed ID: 18546325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of cryoglobulinaemia in hepatitis C virus- and hepatitis C virus/human immunodeficiency virus-infected individuals: implications for renal function.
    Lapinski TW; Parfieniuk A; Rogalska-Plonska M; Czajkowska J; Flisiak R
    Liver Int; 2009 Sep; 29(8):1158-61. PubMed ID: 19602133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of a simple model for predicting liver fibrosis in HIV/hepatitis C virus-coinfected patients.
    Al-Mohri H; Cooper C; Murphy T; Klein MB
    HIV Med; 2005 Nov; 6(6):375-8. PubMed ID: 16268817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
    Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
    J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
    Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
    HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome.
    Castellares C; Barreiro P; Martín-Carbonero L; Labarga P; Vispo ME; Casado R; Galindo L; García-Gascó P; García-Samaniego J; Soriano V
    J Viral Hepat; 2008 Mar; 15(3):165-72. PubMed ID: 18233989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy?
    Cicconi P; Cozzi-Lepri A; Phillips A; Puoti M; Antonucci G; Manconi PE; Tositti G; Colangeli V; Lichtner M; Monforte Ad;
    AIDS; 2007 Mar; 21(5):599-606. PubMed ID: 17314522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mortality related to chronic hepatitis B and chronic hepatitis C in France: evidence for the role of HIV coinfection and alcohol consumption.
    Marcellin P; Pequignot F; Delarocque-Astagneau E; Zarski JP; Ganne N; Hillon P; Antona D; Bovet M; Mechain M; Asselah T; Desenclos JC; Jougla E
    J Hepatol; 2008 Feb; 48(2):200-7. PubMed ID: 18086507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nevirapine pharmacokinetics in HIV-infected and HIV/HCV-coinfected individuals.
    Vogel M; Bertram N; Wasmuth JC; Wyen C; Voigt E; Schwarze-Zander C; Sudhop T; Fätkenheuer G; Rockstroh JK; Reichel C
    J Antimicrob Chemother; 2009 May; 63(5):988-91. PubMed ID: 19270314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.